Overview: Candida Species Identification TestIntroduction: The Candida Species Identification Test identifies Candida species in stool to diagnose infections, causing diarrhea. Following 2023 IDSA guidelines, it uses biochemical methods for high specificity, supporting infection screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in clinical pathology for patients with suspected Candida infections.
Other Names: Candida Identification Assay, Fungal Culture Test.
FDA Status: Laboratory-developed test (LDT), meeting clinical pathology standards for diagnostic accuracy.
Historical Milestone: Candida identification testing began in the 1970s with fungal research. Biochemical methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Identifies Candida species to diagnose infections, guides treatment, and evaluates patients with diarrhea.
Test Parameters: 1. Candida Species Presence
Pretest Condition: No fasting required. Collect stool, vaginal swab, oral swab, or other swabs. Report history of diarrhea or fungal symptoms.
Specimen: Stool (sterile container, 5-10 gm), Vaginal Swab (sterile swab/transport medium, 1-2 swabs), Oral Swab (sterile swab/transport medium, 1-2 swabs). Transport in a biohazard container.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not frozen
Medical History: Document diarrhea, thrush, or history of fungal infections. Include current medications, especially antifungals.
Consent: Written consent required, detailing the tests purpose, Candida infection implications, and risks of sample collection.
Procedural Considerations: Uses culture or biochemical assays to identify Candida species (e.g., C. albicans, C. glabrata). Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for fungal infection diagnosis.
Factors Affecting Result Accuracy: Improper sample collection or contamination can affect results. Antifungal use may reduce sensitivity.
Clinical Significance: Positive Candida species confirm infection, guiding antifungal therapy. Negative results may require PCR or repeat culture.
Specialist Consultation: Consult an infectious disease specialist for result interpretation and treatment planning.
Additional Supporting Tests: Candida PCR, fungal culture, or clinical evaluation to confirm Candida infection diagnosis.
Test Limitations: Limited to detectable species; clinical correlation is needed. Sample quality affects sensitivity.
References: IDSA Fungal Guidelines, 2023; Clinical Infectious Diseases, Pappas PG, 2022.
